Tag: TwiceaYear

Latest News

New Long-Term Data Show that Twice-a-Year Dosing with Inclisiran Results in Persistent Lowering of LDL Cholesterol with No Material Safety Observations Out to Three Years

MIAMI–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MDCO&src=ctag" target="_blank"gt;$MDCOlt;/agt; lt;a href="https://twitter.com/hashtag/cholesterol?src=hash" target="_blank"gt;#cholesterollt;/agt;–The Medicines Company (NASDAQ: MDCO) today announced interim results from the ongoing ORION-3 open-label extension study (Group 1, n=290)...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy